z-logo
open-access-imgOpen Access
The phospholipase A2 signaling as a new therapeutic biomarker of Alzheimer’s disease: modulation through phage display-derived peptides able to cross the blood-brain barrier
Author(s) -
Séverine André,
Fatima Daldal,
Marine Lecomte,
Robert N. Müller,
Luce Vander Elst,
Sophie Laurent,
Carmen Burtéa
Publication year - 2017
Publication title -
frontiers in neuroscience
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.499
H-Index - 102
eISSN - 1662-4548
pISSN - 1662-453X
DOI - 10.3389/conf.fnins.2017.94.00057
Subject(s) - phage display , blood–brain barrier , phospholipase a2 , transcytosis , cancer research , biology , receptor , microbiology and biotechnology , neuroscience , chemistry , peptide , central nervous system , biochemistry , enzyme , endocytosis

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here